In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
At a cost of around $1,400 a month Rexulti's makers, Otsuka and Lundbeck, are forecasting an additional $1 billion in annual sales, but there are serious questions about the harm-benefit balance of this drug, writes investigative journalist Robert Whitaker in The BMJ today.
On efficacy, the drug showed a maximum 5.3-point improvement over placebo on a 174-point scale, far short of the 17 points considered to be clinically important. Schneider says the FDA has a "lower standard of approval" today than it did 20 years ago, a theme echoed by Zeldes, who said: "We are very disappointed that the FDA approved this additional label indication for brexpiprazole on such weak data. The FDA has set a dangerous precedent about the data it may require for future drug approvals for this vulnerable patient group."
Whitaker notes that a number of patient advocacy groups, such as the Alliance for Aging Research, Leaders Engage on Alzheimer's Research , and Us Against Alzheimer's, urged the FDA to approve brexpiprazole.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementiaIn trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
Læs mere »
Donald Trump’s racketeering indictment is the most sweeping yetA Georgia prosecutor lays out her claims of a criminal enterprise
Læs mere »
Experts gather for first Marches Real Food and Farming ConferenceThe inaugural Marches Real Food and Farming Conference will be held next month.
Læs mere »
RSPB to protect 15 million square feet of Scottish wildflowers with baby food dealA PARTNERSHIP between a food brand and a conservation charity is set to protect 15 million square feet of Scottish wildflower meadow.
Læs mere »
eórna Edinburgh: Beautiful food, expertly cookedOn a summer’s evening I step from the blazing sunshine of Stockbridge’s Hamilton Place into the cool hush of eórna. There’s a handsome curved…
Læs mere »
Scientists issue warning over Covid rise suggesting masks should be worn againA new sub-strain, which has not yet been formally named, has been identified
Læs mere »